Impacts of Chemerin Levels and Antioxidant Capacity on the Severity of Cardiovascular Autonomic Neuropathy in Patients with Type 2 Diabetes and Prediabetes
Existing evidence supports an association between chemerin levels and cardiovascular risk, while reduced thiol levels are linked to diabetes mellitus. It is hypothesized that chemerin may contribute to autonomic dysfunction and cardiovascular risk in type 2 diabetes mellitus (T2DM), potentially medi...
Main Authors: | Yun-Ru Lai, Chih-Cheng Huang, Ben-Chung Cheng, Wen-Chan Chiu, Ting-Yin Lin, Hui-Ching Chiang, Chun-En Kuo, Cheng-Hsien Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/11/3024 |
Similar Items
-
No clear evidence of neuropathy among patients with high risk for the development of prediabetes/diabetes—a pilot study
by: Anna E. Körei, et al.
Published: (2024-01-01) -
Parasympathetic and Sympathetic Monitoring Identifies Earliest Signs of Autonomic Neuropathy
by: Nicholas L. DePace, et al.
Published: (2022-07-01) -
Accuracy of autonomic symptoms in detection of severe cardiac autonomic neuropathy
by: Tahniyah Haq, et al.
Published: (2022-07-01) -
Accuracy of autonomic symptoms in detection of severe cardiac autonomic neuropathy
by: Tahniyah Haq, et al.
Published: (2022-07-01) -
Subclinical diagnosis of cardiovascular autonomic neuropathy in type 2 diabetes: prevalence, severity, correlations with time, metabolic and vascular factors
by: Alexandra Diana Comanescu
Published: (2010-03-01)